Bauersachs, J., Heck, M., Fraccarollo, D., Hildemann, S. K., Ertl, G., Wehling, M., & Christ, M. (2002). Addition of spironolactone to angiotensin-converting enzyme inhibition in heart failure improves endothelial vasomotor dysfunction: Role of vascular superoxide anion formation and endothelial nitric oxide synthase expression. Journal of the American College of Cardiology, 39(2), . https://doi.org/10.1016/S0735-1097(01)01729-6
Chicago-Zitierstil (17. Ausg.)Bauersachs, Johann, Marina Heck, Daniela Fraccarollo, Steven K. Hildemann, Georg Ertl, Martin Wehling, und Michael Christ. "Addition of Spironolactone to Angiotensin-converting Enzyme Inhibition in Heart Failure Improves Endothelial Vasomotor Dysfunction: Role of Vascular Superoxide Anion Formation and Endothelial Nitric Oxide Synthase Expression." Journal of the American College of Cardiology 39, no. 2 (2002). https://doi.org/10.1016/S0735-1097(01)01729-6.
MLA-Zitierstil (9. Ausg.)Bauersachs, Johann, et al. "Addition of Spironolactone to Angiotensin-converting Enzyme Inhibition in Heart Failure Improves Endothelial Vasomotor Dysfunction: Role of Vascular Superoxide Anion Formation and Endothelial Nitric Oxide Synthase Expression." Journal of the American College of Cardiology, vol. 39, no. 2, 2002, https://doi.org/10.1016/S0735-1097(01)01729-6.